HOXA9 and MEIS1 gene overexpression in the diagnosis of childhood acute leukemias: Significant correlation with relapse and overall survival

Leukemia Research

Volumn 39, Issue 8, 2015, Pages 874-882

  Adamaki, Maria ^a   Lambrou, George I ^a   Athanasiadou, Anastasia ^a   Vlahopoulos, Spiros ^a   Papavassiliou, Athanasios G ^b   Moschovi, Maria ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Childhood leukemia; Gene overexpression; HOXA9; MEIS1; Overall survival; Relapse

Indexed keywords

TRANSCRIPTION FACTOR HOXA9; HOMEODOMAIN PROTEIN; MYELOID ECOTROPIC VIRAL INTEGRATION SITE 1 PROTEIN; TUMOR MARKER; TUMOR PROTEIN;

ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER SURVIVAL; CELL MATURATION; CHILD; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; CORRELATIONAL STUDY; CYTOGENETICS; DISEASE FREE SURVIVAL; DRUG TREATMENT FAILURE; FEMALE; GENE; GENE OVEREXPRESSION; GENE TRANSLOCATION; HOXA9 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKEMIA CELL LINE; LEUKEMIA FREE TIME; LEUKEMIA RELAPSE; MAJOR CLINICAL STUDY; MALE; MEIS1 GENE; MINIMAL RESIDUAL DISEASE; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCHOOL CHILD; SURVIVAL PREDICTION; T CELL LEUKEMIA; ADOLESCENT; GENE EXPRESSION REGULATION; GENETICS; INFANT; MORTALITY; PATHOLOGY; PROGNOSIS; RECURRENT DISEASE; SURVIVAL; UPREGULATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION REGULATION, LEUKEMIC; HOMEODOMAIN PROTEINS; HUMANS; INFANT; MALE; NEOPLASM PROTEINS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; RECURRENCE; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84937514220     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2015.04.012     Document Type: Article

References (35)

1. Argiropoulos B., Yung E., Humphries R.K. Unraveling the crucial roles of Meis1 in leukemogenesis and normal hematopoiesis. Genes Dev 2007, 21:2845-2849.
2. Abramovich C., Humphries R.K. Hox regulation of normal and leukemic hematopoietic stem cells. Curr Opin Hematol 2005, 12:210-216.
3. Bijl J., Thompson A., Ramirez-Solis R., et al. Analysis of HSC activity and compensatory Hox gene expression profile in Hoxb cluster mutant fetal liver cells. Blood 2006, 108:116-122.
4. Pineault N., Helgason C.D., Lawrence H.J., Humphries R.K. Differential expression of Hox, Meis1, and Pbx1 genes in primitive cells throughout murine hematopoietic ontogeny. Exp Hematol 2002, 30:49-57.
5. Lawrence H.J., Helgason C.D., Sauvageau G., et al. Mice bearing a targeted interruption of the homeobox gene HOXA9 have defects in myeloid, erythroid, and lymphoid hematopoiesis. Blood 1997, 89:1922-1930.
6. Hisa T., Spence S.E., Rachel R.A., et al. Hematopoietic, angiogenic and eye defects in Meis1 mutant animals. EMBO J 2004, 23:450-459.
7. Wang G.G., Pasillas M.P., Kamps M.P. Meis1 programs transcription of FLT3 and cancer stem cell character, using a mechanism that requires interaction with Pbx and a novel function of the Meis1 C-terminus. Blood 2005, 106:254-264.
8. Sitwala K.V., Dandekar M.N., Hess J.L. HOX proteins and leukemia. Int J Clin Exp Pathol 2008, 1:461-474.
9. Fujino T., Yamazaki Y., Largaespada D.A., et al. Inhibition of myeloid differentiation by Hoxa9, Hoxb8, and Meis homeobox genes. Exp Hematol 2001, 29:856-863.
10. Wang G.G., Pasillas M.P., Kamps M.P. Persistent transactivation by meis1 replaces hox function in myeloid leukemogenesis models: evidence for co-occupancy of meis1-pbx and hox-pbx complexes on promoters of leukemia-associated genes. Mol Cell Biol 2006, 26:3902-3916.
11. Wong P., Iwasaki M., Somervaille T.C., So C.W., Cleary M.L. Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential. Genes Dev 2007, 21:2762-2774.
12. Brumatti G., Salmanidis M., Kok C.H., et al. HoxA9 regulated Bcl-2 expression mediates survival of myeloid progenitors and the severity of HoxA9-dependent leukemia. Oncotarget 2013, 4:1933-1947.
13. Orlovsky K., Kalinkovich A., Rozovskaia T., et al. Down-regulation of homeobox genes MEIS1 and HOXA in MLL-rearranged acute leukemia impairs engraftment and reduces proliferation. Proc Natl Acad Sci U S A 2011, 108:7956-7961.
14. Soulier J., Clappier E., Cayuela J.M., et al. HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL). Blood 2005, 106:274-286.
15. Beachy S.H., Onozawa M., Silverman D., Chung Y.J., Rivera M.M., Aplan P.D. Isolated Hoxa9 overexpression predisposes to the development of lymphoid but not myeloid leukemia. Exp Hematol 2013, 41. e5, 518-29.
16. Rozovskaia T., Feinstein E., Mor O., et al. Upregulation of Meis1 and HoxA9 in acute lymphocytic leukemias with the t(4:11) abnormality. Oncogene 2001, 20:874-878.
17. Faber J., Krivtsov A.V., Stubbs M.C., et al. HOXA9 is required for survival in human MLL-rearranged acute leukemias. Blood 2009, 113:2375-2385.
18. Asnafi V., Radford-Weiss I., Dastugue N., et al. CALM-AF10 is a common fusion transcript in T-ALL and is specific to the TCRgammadelta lineage. Blood 2003, 102:1000-1006.
19. Choi C.W., Chung Y.J., Slape C., Aplan P.D. A NUP98-HOXD13 fusion gene impairs differentiation of B and T lymphocytes and leads to expansion of thymocytes with partial TCRB gene rearrangement. J Immunol 2009, 183:6227-6235.
20. Serrano E., Lasa A., Perea G., et al. Acute myeloid leukemia subgroups identified by pathway-restricted gene expression signatures. Acta Haematol 2006, 116:77-89.
21. Andreeff M., Ruvolo V., Gadgil S., et al. HOX expression patterns identify a common signature for favorable AML. Leukemia 2008, 22:2041-2047.
22. Li D.P., Li Z.Y., Sang W., Cheng H., Pan X.Y., Xu K.L. HOXA9 gene expression in acute myeloid leukemia. Cell Biochem Biophys 2013, 67:935-938.
23. Imamura T., Morimoto A., Takanashi M., et al. Frequent co-expression of HoxA9 and Meis1 genes in infant acute lymphoblastic leukaemia with MLL rearrangement. Br J Haematol 2002, 119:119-121.
24. Danen-van Oorschot A.A., Kuipers J.E., Arentsen-Peters S., et al. Differentially expressed miRNAs in cytogenetic and molecular subtypes of pediatric acute myeloid leukemia. Pediatric Blood Cancer 2012, 58:715-721.
25. Fang K., Han B.W., Chen Z.H., et al. A distinct set of long non-coding RNAs in childhood MLL-rearranged acute lymphoblastic leukemia: biology and epigenetic target. Hum Mol Genet 2014, 23:3278-3288.
26. Lambrou G.I., Vlahopoulos S., Papathanasiou C., et al. Prednisolone exerts late mitogenic and biphasic effects on resistant acute lymphoblastic leukemia cells: Relation to early gene expression. Leuk Res 2009, 33:1684-1695.
27. Adamaki M., Lambrou G.I., Athanasiadou A., Tzanoudaki M., Vlahopoulos S., Moschovi M. Implication of IRF4 aberrant gene expression in the acute leukemias of childhood. PloS One 2013, 8:e72326.
28. Armstrong S.A., Golub T.R., Korsmeyer S.J. MLL-rearranged leukemias: insights from gene expression profiling. Seminars Hematol 2003, 40:268-273.
29. Tsutsumi S., Taketani T., Nishimura K., et al. Two distinct gene expression signatures in pediatric acute lymphoblastic leukemia with MLL rearrangements. Cancer Res 2003, 63:4882-4887.
30. Ayton P.M., Cleary M.L. Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9. Genes Dev 2003, 17:2298-2307.
31. Borrow J., Shearman A.M., Stanton V.P., et al. The t(7;11)(p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP98 and class I homeoprotein HOXA9. Nat Genet 1996, 12:159-167.
32. Golub T.R., Slonim D.K., Tamayo P., et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science (New York, NY) 1999, 286:531-537.
33. Quentmeier H., Dirks W.G., Macleod R.A., Reinhardt J., Zaborski M., Drexler H.G. Expression of HOX genes in acute leukemia cell lines with and without MLL translocations. Leukemia Lymphoma 2004, 45:567-574.
34. Drabkin H.A., Parsy C., Ferguson K., et al. Quantitative HOX expression in chromosomally defined subsets of acute myelogenous leukemia. Leukemia 2002, 16:186-195.
35. Kumar A.R., Li Q., Hudson W.A., et al. A role for MEIS1 in MLL-fusion gene leukemia. Blood 2009, 113:1756-1758.